Recombinant Anti-IL13 x Anti-IL4 Bispecific Antibody (Tandem scFv)
TypeName: Business Offer
Category:
Country: United States
Summary: Recombinant Anti-IL13 x Anti-IL4 Bispecific Antibody (Tandem scFv) is designed to be expressed as a scFv from an anti-IL13 antibody variable domains fused with a scFv from an anti-IL4 antibody variable domains. It contains a His-tag at the C/N terminus for affinity purification. The BsAb exits as monomer in reducing and non-reducing conditions. This BsAb can block two proinflammatory cytokines simultaneously. It is designed for the research of Idiopathic pulmonary fibrosis therapy. https://www.creative-biolabs.com/bsab/symbolsearch-il13%2520%2526%2520il4.htm
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
